EGRX
Eagle Pharmaceuticals Inc
Price:  
3.74 
USD
Volume:  
125,080.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

EGRX Intrinsic Value

%
Upside

As of 2024-05-28, the Intrinsic Value of Eagle Pharmaceuticals Inc (EGRX) is 35.05 USD. This EGRX valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 3.74 USD, the upside of Eagle Pharmaceuticals Inc is %.

The range of the Intrinsic Value is 29.25 - 43.77 USD

3.74 USD
Stock Price
35.05 USD
Intrinsic Value
Intrinsic Value Details

EGRX Intrinsic Value - Valuation Summary

Range Selected Upside
a
DCF (Growth 5y) 29.25 - 43.77 35.05 837.3%
DCF (Growth 10y) 33.02 - 47.93 39.01 943.0%
DCF (EBITDA 5y) 34.31 - 42.37 38.85 938.8%
DCF (EBITDA 10y) 36.43 - 46.00 41.45 1008.3%
Fair Value 23.29 - 23.29 23.29 522.65%
P/E 23.88 - 53.78 38.37 925.9%
EV/EBITDA 32.45 - 73.09 56.32 1405.9%
EPV 26.14 - 34.42 30.28 709.6%
DDM - Stable 4.32 - 8.17 6.25 67.1%
DDM - Multi 9.15 - 14.15 11.17 198.6%

EGRX Intrinsic Value - Key Valuation Metrics

Market Cap (mil) 48.58
Beta -0.51
Outstanding shares (mil) 12.99
Enterprise Value (mil) 103.38
Market risk premium 4.60%
Cost of Equity 13.17%
Cost of Debt 5.06%
WACC 7.41%